SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending due to escalating geopolitical tensions in the Middle East involving the US and Iran, sparking a highly divided community debate between those anticipating a significant market downturn and others who view it as a "buy the dip" opportunity, arguing the events are already priced in.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is trending as escalating geopolitical tensions in the Middle East, including military actions and potential disruptions to the Strait of Hormuz, are driving strong community anticipation for rapidly surging oil prices. Traders view XOM as a prime beneficiary and a key hedge against the broader market volatility.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amidst escalating Middle East tensions, with market participants sharply divided between expectations of a significant tech sell-off due to rising oil prices and concerns over global stability, versus a 'buy the dip' mentality fueled by beliefs of market resilience and potential liquidity injections.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as news of its N704AX airworthiness certification and impending piloted VTOL flights ignites investor enthusiasm, further fueled by a Starlink partnership and UK defense expansion. While many anticipate significant milestones like upcoming earnings and eVTOL program selections, skepticism regarding development timelines and revenue generation remains a key talking point.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

Escalating U.S.-Israeli strikes on Iran, followed by Iranian retaliation and a halt in tanker traffic through the critical Strait of Hormuz, are intensely fueling discussion around USO as the community debates a potential "war premium" spike versus a temporary "sell the news" event amid broader inflation concerns.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending amidst escalating geopolitical tensions in the Middle East, with oil prices surging due to fears of supply disruptions and the potential closure of the critical Strait of Hormuz. The community anticipates a significant upward move for low-float oil stocks like INDO, with many discussing a potential short squeeze and drawing comparisons to previous parabolic runs driven by global conflicts.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius (NBIS) is actively discussed as it faces downward pressure, primarily in sympathy with a competitor's earnings and heightened geopolitical tensions, prompting community debate over whether current market volatility presents a compelling "buy the dip" opportunity given NBIS's strong backlog and sound financial fundamentals.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as escalating geopolitical tensions fuel investor speculation about increased demand for its FPV 'kamikaze' drones and uncrewed surface vessels (USVs) for defense. The community is actively discussing the immediate relevance of its Black Widow and FANG drones to current conflicts and the potential for significant contract awards from the US Army's 'Drone Dominance' program.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as community debate intensifies over recent geopolitical events driving market volatility and creating a "buy the dip" opportunity. This comes amidst news of a powerful new AI inference chip and strategic 6G partnerships anticipated ahead of its developer conference.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is heavily trending amid escalating geopolitical tensions in the Middle East, with community discussion centered on the potential for massive defense orders and a significant short squeeze for drone stocks. Investors are highlighting Ondas's strategic position in defense initiatives, including its Israeli partnerships and participation in the U.S. Drone Dominance Program, driving expectations for a substantial upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs

Turn Therapeutics, Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunology therapies for dermatologic conditions, today announced the appointment...

Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences

Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunology therapies for dermatology, today announced that Brad Burnam, Chief...

Turn Therapeutics' (TTRX) Buy Rating Reiterated at D. Boral Capital

D. Boral Capital restated a "buy" rating and issued a $8.00 price target on shares of Turn Therapeutics in a report on Tuesday...

Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference

Turn Therapeutics, Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunological therapies for dermatologic and infectious diseases, today announced...

Turn Therapeutics (NASDAQ:TTRX) Upgraded to "Strong-Buy" at D Boral Capital

D Boral Capital upgraded shares of Turn Therapeutics to a "strong-buy" rating in a research report on Monday...

Turn Therapeutics (NASDAQ:TTRX) Coverage Initiated at D. Boral Capital

D. Boral Capital assumed coverage on Turn Therapeutics in a research report on Monday. They set a "buy" rating and a $8.00 price target on the stock...

Turn Therapeutics (NASDAQ:TTRX) Director Purchases $33,945.92 in Stock

Turn Therapeutics Inc. (NASDAQ:TTRX - Get Free Report) Director Arthur Golden bought 9,868 shares of Turn Therapeutics stock in a transaction that occurred on Monday, November 24th. The stock was...

Insider Buying: Turn Therapeutics (NASDAQ:TTRX) Director Buys 20,532 Shares of Stock

Turn Therapeutics Inc. (NASDAQ:TTRX - Get Free Report) Director Arthur Golden acquired 20,532 shares of Turn Therapeutics stock in a transaction dated Friday, November 21st. The shares were bought at...

Turn Therapeutics (NASDAQ:TTRX) Releases Quarterly Earnings Results

Turn Therapeutics (NASDAQ:TTRX - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.07) EPS for the quarter...

Shares of Turn Therapeutics&nbsp;surged over 370% in early premarket trade on Thursday,&nbsp;extending&nbsp;gains&nbsp;from the after-hours session on the Nasdaq Capital Market after the California-based biotech made its public listing on Wednesday.&nbsp;The U.S. Securities and Exchange Commission had declared Turn’s registration statement effective on Sept. 30, clearing the way for the IPO.<a href="https://stocktwits.com/symbol/TTRX">Turn Therapeutics’ stock</a> surged 134% to $9.40 in extended trading on Wednesday, placing it among the top after-hours gainers on the day.Founder and CEO Bradley Burnham said during the Nasdaq closing bell ceremony that the company was “built on a shoestring, with an absolute disdain for waste,” highlighting its lean approach to research and operations.&nbsp;Turn Therapeutics develops and commercializes next-generation products for dermatology, wound care, and infectious diseases, with three FDA-cleared medical devices and late-stage clinical programs in eczema and onychomycosis.&nbsp;Its proprietary formula targets inflammatory cytokines such as IL-36a, IL-36y, IL-4, and IL-31, and has been confirmed as non-cytotoxic and non-sensitizing.&nbsp;The company also develops formulations that are 99.9% effective against Methicillin-Resistant Staphylococcus aureus, a type of bacteria that’s resistant to many commonly used antibiotics, and qualify for the FDA’s Qualified Infectious Disease Product (QIDP) program.Turn has also developed its Permafusion platform, which allows pharmaceutical ingredients to penetrate deeper skin and tissue layers without emulsifiers, improving bioavailability and minimizing side effects.&nbsp;Beyond dermatology and wound care, Turn is developing thermostable vaccine delivery technology to expand access to essential medicines in underserved global markets.The company’s financial advisor for the listing was Clear Street LLC, with legal counsel provided by Davis Polk &amp; Wardwell LLP.&nbsp;On Stocktwits, retail sentiment was ‘neutral’ amid ‘extremely low’ message volume.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Turn Therapeutics’ stock (TTRX) surged 134% to $9.40 in extended trading on Wednesday, placing it among the top after-hours gainers on the day. (Representative Image: Getty Images)

Why Is Turn Therapeutics Stock Soaring Over 370% Premarket Today?

The stock’s debut on Wednesday followed the SEC’s approval of its registration statement on Sept. 30, clearing the way for its public listing as it advances late-stage clinical programs in eczema and onychomycosis.

Equity

Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. Its primary development programs focus on dermatological diseases. The company was founded on January 6, 2015 and is headquartered in Westlake Village, CA.

Turn Therapeutics Inc.

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Current Price	$3.60
Prev Close	$3.84
Open	$3.76
Dividend Yield	N/A
50-Day Moving Average	$3.92
Beta	1.56
Avg. Volume	52,534.75
PE Ratio	-27.19

52-Week High	$26.50
52-Week Low	$2.57
Market Capitalization	$106M
EPS (Annual)	-$0.1318
Price to Book	181.18
Revenue Per Employee	N/A

TTRX
Turn Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TTRX News

TTRXTurn Therapeutics Inc